Raising Phelan-McDermid Syndrome Awareness (And How YOU Can Get Involved at the EL-PFDD Meeting!): An Interview with Geraldine Bliss (Pt. 2)
Photo courtesy of Geraldine Bliss

Raising Phelan-McDermid Syndrome Awareness (And How YOU Can Get Involved at the EL-PFDD Meeting!): An Interview with Geraldine Bliss (Pt. 2)

Before you read on, make sure to check out Part 1 of our interview with Geraldine Bliss, the President and Co-Founder of CureSHANK and mother to Charles, who has Phelan-McDermid syndrome. Today,…

Continue Reading Raising Phelan-McDermid Syndrome Awareness (And How YOU Can Get Involved at the EL-PFDD Meeting!): An Interview with Geraldine Bliss (Pt. 2)
Becoming an Advocate for Phelan-McDermid Syndrome (PMS): Lacy and Avenly’s Story
Photo courtesy of Lacy Biram

Becoming an Advocate for Phelan-McDermid Syndrome (PMS): Lacy and Avenly’s Story

Prior to her daughter Avenly’s diagnosis, Lacy Biram had never before heard of Phelan-McDermid syndrome (PMS). Currently, there are an estimated 2,200-3,000 people worldwide who have this rare condition. For…

Continue Reading Becoming an Advocate for Phelan-McDermid Syndrome (PMS): Lacy and Avenly’s Story
Raising Phelan-McDermid Syndrome Awareness (And How YOU Can Get Involved at the EL-PFDD Meeting!): An Interview with Geraldine Bliss (Pt. 1)
Photo courtesy of Geraldine Bliss

Raising Phelan-McDermid Syndrome Awareness (And How YOU Can Get Involved at the EL-PFDD Meeting!): An Interview with Geraldine Bliss (Pt. 1)

On November 8th, 2022, CureSHANK is sponsoring an Externally-Led Patient-Focused Drug Development (EL-PFDD) Meeting for Phelan-McDermid Syndrome (PMS). Co-planned by the Phelan-McDermid Syndrome Foundation, this virtual EL-PFDD meeting will: [give]…

Continue Reading Raising Phelan-McDermid Syndrome Awareness (And How YOU Can Get Involved at the EL-PFDD Meeting!): An Interview with Geraldine Bliss (Pt. 1)
Experimental Treatment for Alpha-1 Antitrypsin Deficiency Earns Fast Track Designation
source: unsplash.com

Experimental Treatment for Alpha-1 Antitrypsin Deficiency Earns Fast Track Designation

According to a story from globenewswire.com, the biopharmaceutical company Mereo BioPharma Group plc has recently announced that the company's investigational therapeutic alvelestat has earned Fast Track designation from the US…

Continue Reading Experimental Treatment for Alpha-1 Antitrypsin Deficiency Earns Fast Track Designation

Treatment for Adult Patients with Chronic Immune Thrombocytopenia (ITP) is Now Available in the UK

Fostamatinib is a spleen tyrosine kinase (SYK) inhibitor recommended to treat ITP patients who have been unable to receive a sufficient response from other medications. TAVLESSE® (fostamatinib), developed by Grifols…

Continue Reading Treatment for Adult Patients with Chronic Immune Thrombocytopenia (ITP) is Now Available in the UK
“For Seven Years I Thought I had a Perfectly Healthy Child” – Jessica’s Story
source: unsplash.com

“For Seven Years I Thought I had a Perfectly Healthy Child” – Jessica’s Story

This story was originally published by the Family Heart Foundation, a Patient Worthy partner organization. When Jessica’s father died of a heart attack at the young age of 54, she…

Continue Reading “For Seven Years I Thought I had a Perfectly Healthy Child” – Jessica’s Story